Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 2001
Medical Areas: Pulmonary/Respiratory Diseases

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Tavist (clemastine fumarate)

Company: Novartis
Approval Status: Approved March 2001
Treatment Area: Cold and Allergy

General Information

Tavist Allergy/Sinus/Headache, an over-the-counter medication, has been approved for the temporary relief of symptoms associated with hay fever, allergic rhinitis, and the common cold. These may include, sinus congestion and pressure, runny nose and sneezing, itchy throat, and itchy, watery eyes. Tavist Allergy/Sinus/Headache is the only over-the-counter medication to combine the antihistamine clemastine fumarate with a nasal decongestant and pain reliever.

Side Effects

General adverse events associated with the use of an analgesic, antihistamine, decongestant combination medication may include (but are not limited to) the following:


  • Drowsiness
  • Nausea
  • Stomach pain

Mechanism of Action

Tavist Allergy/Sinus/Headache contains the analgesic acetaminophen, the antihistamine clemastine fumarate, and the decongestant pseudoephedrine hydrochloride.

Additional Information

For additional information on Tavist Allergy/Sinus/Headache, please visit Novartis Consumer Products.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.